Harvard: Building a Future-Forward Digital Health Venture

  • February 16, 2022
When:
February 18, 2022 @ 4:00 am – 5:00 am Australia/Sydney Timezone
2022-02-18T04:00:00+11:00
2022-02-18T05:00:00+11:00
Harvard: Building a Future-Forward Digital Health Venture

Dear Oxbridge Partners and Affiliates,

All Oxbridge members are part of Harvard Alumni Entrepreneurs. HAE’s mission like Oxbridge is to foster entrepreneurship. Be your own boss and stop helping others achieve their dream and start building your own.

Join HAE Digital Medicine salon for a fascinating conversation with Jim Harper, the founder and chief operating officer of Sonde Health (Market value over 25M USD). Jim will introduce Sonde Health and vocal biomarkers as a remote health measurement technology platform and will address questions intended to give attendees deeper insight into the journey of a digital biotech startup and key decisions that founders and leaders face on that path.

Discussion topics will include: essential components for building a scientifically sound and commercially viable digital health venture; challenges of AI-driven digital screening technology development, and learnings from Sonde’s commercialization and financing journey that may provide useful insights for other founders and investors interested in building digital biomarker products and markets.

Event Moderator: Gergana Koleva, MSc ‘14

About our Guest

Jim Harper is the co-founder and chief operating officer of Sonde Health and has over 25 years of experience developing innovative technologies as solutions to important biological measurement problems. At Sonde he is building the platform to harness voice as a meaningful indicator of health using devices we already own. Prior to Sonde, he was at MIT Lincoln Laboratory for 15 years where he led development of new biotechnology and bioengineering capabilities and teams for a range of national security applications and government agencies. Jim earned his PhD in biochemistry from MIT and was a postdoctoral research fellow at Harvard Medical School in the Center for Neurologic Diseases.

    Leave Your Comment Here

    Help-Desk